-
Three Takeaways From ADA Clinical Updates: Turning Standards Into Practice
If you work in diabetes care and education and are a member of the American Diabetes Association, you’ve likely received the nearly 400-page Standards of Care journal in your mailbox. What began as a three-page reference document in 1989 has grown into a comprehensive resource that now rivals a phonebook. The depth of guidance is incredibly valuable, but translating all of those standards into day-to-day clinical practice can feel a bit daunting. Enter the ADA Clinical Updates Conference, an important piece of the puzzle that focuses on moving evidence off the page and into real-world care. After spending the weekend…
-
Nutrition and Type 1 Diabetes: What Are Best Practices for Insulin Dosing?
I recently had the opportunity to contribute to an upcoming text from the American Diabetes Association on nutrition therapy in diabetes care. Specifically, I was tasked with reviewing and rewriting a chapter on nutrition recommendations for adults with type 1 diabetes and insulin-requiring type 2. In my excitement for its upcoming publication, I want to share a preview of some best practices for insulin dosing for individuals on multiple daily injections (MDI). What are the strategies for dosing insulin with meals? How can doses be adjusted? And how do factors like exercise, alcohol, or stress come into play? I hope…
-
Nutrition and Type 1 Diabetes: What about Protein and Fat?
I recently had the opportunity to contribute to an upcoming text from the American Diabetes Association on nutrition therapy in diabetes care. Specifically, I was tasked with reviewing and rewriting a chapter on nutrition recommendations for adults with type 1 diabetes and insulin-requiring type 2. In my excitement for its upcoming publication, I want to share a preview of my key findings on the role of fat and protein. Does fat and protein impact glycemic? What is the ideal amount? Does it require additional insulin? I hope this sneak peek sparks curiosity and encourages you to consider adding this valuable resource…
-
Nutrition and Type 1 Diabetes: Do Carbohydrates Matter?
I recently had the opportunity to contribute to an upcoming text from the American Diabetes Association on nutrition therapy in diabetes care. Specifically, I was tasked with reviewing and rewriting a chapter on nutrition recommendations for adults with type 1 diabetes and insulin-requiring type 2. In my excitement for its upcoming publication, I’d like to share a preview of some key findings on carbohydrates. Is carbohydrate counting still relevant today? Does the type of carbohydrate make a difference? And how do approaches like low-carb or keto eating fit in? My hope is that this sneak peek sparks curiosity and inspires…
-
Nutrition and Type 1 Diabetes: A Four-Part Series
I recently had the opportunity to contribute to an upcoming text from the American Diabetes Association on medical nutrition therapy for the management of diabetes. Specifically, I was tasked with reviewing and substantially rewriting a chapter focused on nutrition therapy recommendations for adults with type 1 diabetes and insulin-requiring type 2 diabetes. This was by far one of the most challenging and rewarding projects I’ve taken on, rivaling even my graduate thesis (which included over 110 citations!). The chapter is deeply researched and reflects countless hours of work, reflection, and revision, though at this point, it all feels like a…
-
Obesity Care vs. Weight Loss: What’s the Difference?
The International Obesity Collaborative, a global alliance of professional organizations focused on improving obesity care, recently released a powerful consensus statement: obesity care and weight loss are not the same. You might be wondering: What’s the difference? Isn’t all obesity care centered around weight loss? And wouldn’t weight loss be appropriate for someone with obesity? The answer may surprise you. Let’s take a closer look at the International Obesity Collaborative’s new consensus statement, what it means for healthcare professionals, and how it could reshape the way we approach obesity treatment in clinical practice.
-
Does CGM Tell the Whole Story? A Second Look at Lingo for Metabolic Monitoring
I recently revisited Lingo, Abbott’s direct-to-consumer continuous glucose monitoring (CGM) system, after a new wave of clients began seeking guidance on how to use it to support metabolic health, including diabetes prevention, insulin resistance, and weight loss. Last fall, I tested and reviewed the device with a focus on its hardware, technical features, usability, and accuracy. This time, however, I’m evaluating Lingo from a different angle: its potential role in health coaching and behavior change. What can continuous glucose monitoring really tell us about metabolic health—or overall well-being? Does it provide the full picture? More importantly, how does it actually…
-
DCES Leadership in the Future of Wearable Health Technology
In a recent issue of Healthcare150, a newsletter spotlighting key healthcare trends, I was struck by the projected growth of wearable devices—from $14.5 billion in 2020 to $76.1 billion by 2029. In my nutrition practice, I see just how common sleep, activity, and glucose trackers have become. This kind of growth points to a broader shift, that digital health tools are becoming deeply integrated into mainstream self care. Wearables are now central to both cost-efficiency efforts in healthcare and the growing demand for a highly personalized approach. Here are a few standout trends—and the exciting opportunities I see for diabetes…
![Sarah Hormachea Diabetes Care and Education - [ ] Nutrition and Type 1 Diabetes: What about Protein and Fat?](https://i0.wp.com/www.sarahhormachea.com/wp-content/uploads/2025/10/Website-Featured-blog-post-1.png?resize=1140%2C763&ssl=1)
